Hinrich Schulenburg

„Incorporating research content on Evolving Health and suitable cooperation partners is my responsibility in the KielSCN. In doing so I will especially focus on areas with high relevance to both science and society and new developments in transdisciplinary research approaches.“

Kiel University
Senior Principal Investigator

E-Mail: hschulenburg@kielscn.de
Telephone: +49 431-880 4141
Website

• since 2008: W3 Professor in Zoology at Kiel University
• 2006 – 2007: invited sabbatical at the Wissenschaftskolleg zu Berlin
• 2005 – 2008: Research scientist (Akademischer Rat) at the Zoological Institute at the University of Tübingen
• 2000 – 2005: PostDoc at the Institute for Evolution and Biodiversity at the University of Münster
• 1996 – 2000: PhD degree at the University of Cambridge, UK
• 1991 – 1996: Studies in Biology at the University Bielefeld and Cambridge University, UK

• Mahrt N., Tietze A., Künzel S., Franzenburg S., Barbosa C., Jansen G., Schulenburg H. (2021). Bottleneck size and selection level reproducibly impact antibiotic resistance evolution. Nature Ecology Evolution 5:1233–1242.
• Batra A., Roemhild R., Rousseau E., Franzenburg S., Niemann S., Schulenburg H. (2021). High potency of sequential therapy with only beta-lactam antibiotics. eLife 10:e68876.
• Kapitza M., Tueffers L., Schulenburg H., Kremer K. (2021). Tracking down resistances: a co-design approach for a biomedical educational program on antibiotic resistance. Science Activities. 58, No. 2, 52-64.
• Claussen C., Knapp J.M., Kapitza M., Bernholt A., Schulenburg H., Kremer K. (2020). Metaorganismusforschung trifft Schule. Biologie in unserer Zeit 50:270-277.
• Roemhild R., Gokhale C.S., Dirksen P., Blake C., Rosenstiel P., Traulsen A., Andersson D.I., Schulenburg H. (2018). Cellular hysteresis as a principle to maximize the efficacy of antibiotic therapy. Proceedings of the National Academy of Science USA 115:9767-9772.

• Evolutionary medicine: sustainable approaches to counter the antibiotic crisis
• Sequential antibiotic therapy to control pathogen evolution
• Evolution of host-microbiome interactions

• since 2019: Speaker of the DFG Research Training Group GRK 2501 on Translational Evolutionary Research (TransEvo)
• 2017 – 2022: Max Planck Fellow at the MPI for Evolutionary Biology in Plön
• since 2016: Vice-speaker of the CRC 1182 Origin and function of metaorganisms
• since 2016: Vice-speaker, Leibniz Science Campus Evolutionary Medicine of the Lung
• since 2016: Speaker of the Kiel Evolution Center